Interleukin-1 in human skin: Dysregulation in psoriasis

62Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cytokine dysregulation is an attractive concept to explain many of the observed abnormalities in psoriasis. IL-1, in particular, can potentiate immune cellular activation, activate fibroblasts, and increase endothelial cell adhesiveness to leukocytes. Here, we review IL-1 regulation in normal and psoriatic skin in vivo in relation to normal skin and cultured keratinocytes. Contrary to expectations, IL-1 functional activity in psoriatic lesions is reduced, not increased, relative to normal skin. The reduction is attributable to the presence of IL-1 inhibitors, reduced IL-lα levels, and an IL-1β that lacked function in T-cell assays. IL-1β protein is actually significantly increased in non-functionality remains unclear. Unlike cultured keratinocytes, which accumulate large, inactive IL-1β precursors, both normal and psoriatic skin process IL-1β to a mature form. Novel mechanisms of post-translational processing by epidermis in vivo may generate a novel form of IL-1β with unknown functions. The marked abnormalities of IL-1 regulation in psoriatic skin suggest that this molecule may be important in normal skin homeostasis. © 1990.

Cite

CITATION STYLE

APA

Cooper, K. D., Hammerberg, C., Baadsgaard, O., Elder, J. T., Chan, L. S., Taylor, R. S., … Fisher, G. (1990). Interleukin-1 in human skin: Dysregulation in psoriasis. Journal of Investigative Dermatology, 95(5). https://doi.org/10.1111/1523-1747.ep12505698

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free